Dr. Daniel E. McLain, PhD, serves as the President and Consulting Toxicologist at Walker Downey & Associates, Inc., a distinguished consulting firm specializing in medical product safety and development. Located in Madison, WI, a hub for scientific and biotechnology innovation, Dr. McLain leads a team...
Dr. Daniel E. McLain, PhD, serves as the President and Consulting Toxicologist at Walker Downey & Associates, Inc., a distinguished consulting firm specializing in medical product safety and development. Located in Madison, WI, a hub for scientific and biotechnology innovation, Dr. McLain leads a team dedicated to providing evidence-based solutions that ensure the biocompatibility of medical devices. His extensive background in nutritional toxicology and preventive medicine, acquired through his MS and PhD from Cornell University, equips him with a unique perspective on the intersection of health and safety in product development.
Under Dr. McLain's leadership, Walker Downey & Associates has undertaken key projects that focus on streamlining the regulatory pathways for medical devices, emphasizing rapid product development without compromising safety standards. His expertise in pharmacokinetics and drug safety plays a critical role in guiding clients through complex clinical trials and ensuring compliance with stringent industry regulations. Dr. McLain is particularly adept at crafting comprehensive protocols that address the nuances of in vitro testing, thereby facilitating the timely advancement of innovative therapeutic solutions.
In addition to his consulting work, Dr. McLain actively contributes to the pharmaceutical industry through medical writing and drug discovery initiatives, where he leverages his knowledge to enhance the understanding of therapeutic areas and improve patient outcomes. As a certified Veteran-Owned Small Business (cVOSB), Walker Downey & Associates embodies Dr. McLain's commitment to excellence and integrity in the field of medical product safety, making significant strides in the development of safe and effective medical technologies.
